Exogenous ifn-alpha administration reduces influenza a virus replication in the lower respiratory tract of rhesus macaques

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Matzinger, Shannon R ^a,b   Carroll, Timothy D ^a,b   Fritts, Linda ^a,b   McChesney, Michael B ^a   Miller, Christopher J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; MYXOVIRUS RESISTANCE PROTEIN A; PEGINTERFERON ALPHA2A; VIRUS RNA; ALPHA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; GENE; GENE EXPRESSION; INFLUENZA VIRUS A; INNATE IMMUNITY; LOWER RESPIRATORY TRACT; MX1 GENE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RHESUS MONKEY; TRACHEA; VIRUS REPLICATION; WEIGHT REDUCTION; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; HUMAN; IMMUNOLOGY; INFLUENZA; LUNG; MACACA MULATTA; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; VIROLOGY;

ANIMALIA; INFLUENZA A VIRUS; MACACA MULATTA; ORTHOMYXOVIRIDAE; PRIMATES;

ANIMALS; BODY TEMPERATURE; BODY WEIGHT; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON-ALPHA; LUNG; MACACA MULATTA; ORTHOMYXOVIRIDAE INFECTIONS; TRACHEA; VIRUS REPLICATION;

EID: 84855273833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029255     Document Type: Article

References (20)

1. Brydon EW, Morris SJ, Sweet C, (2005) Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev 29: 837-850.
2. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, et al. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101: 643-649.
3. Murphy BR, Baron S, Chalhub EG, Uhlendorf CP, Chanock RM, (1973) Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis 128: 488-493.
4. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
5. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
6. Haasbach E, Droebner K, Vogel AB, Planz O, (2011) Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. J Interferon Cytokine Res 31: 515-525.
7. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, et al. (2007) The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81: 10818-10821.
8. Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, et al. (2009) Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol 83: 3843-3851.
9. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hygiene 27: 493-497.
10. Carroll TD, Matzinger SR, Genesca M, Fritts L, Colon R, et al. (2008) Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. J Immunol 180: 2385-2395.
11. Abel K, Rocke DM, Chohan B, Fritts L, Miller CJ, (2005) Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol 79: 12164-12172.
12. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, et al. (2005) The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 79: 14355-14370.
13. Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, et al. (2008) Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol 37: 26-30.
14. Shaker O, Ahmed A, Doss W, Abdel-Hamid M, (2010) MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients. J Viral Hepat 17: 794-799.
15. Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, et al. (2009) Intranasal Administration of Interferon-Alpha Reduces Seasonal Influenza A Virus Morbidity in Ferrets. J Virol.
16. Horisberger MA, Staeheli P, Haller O, (1983) Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci U S A 80: 1910-1914.
17. Pavlovic J, Haller O, Staeheli P, (1992) Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol 66: 2564-2569.
18. Stertz S, Reichelt M, Krijnse-Locker J, Mackenzie J, Simpson JC, et al. (2006) Interferon-induced, antiviral human MxA protein localizes to a distinct subcompartment of the smooth endoplasmic reticulum. J Interferon Cytokine Res 26: 650-660.
19. Haller O, Kochs G, (2002) Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3: 710-717.
20. Turan K, Mibayashi M, Sugiyama K, Saito S, Numajiri A, et al. (2004) Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res 32: 643-652.